Skip to content

DR. TINEKE DE SUTTER

Active
Private limited companyfounded 2023active for 2 yearsMoubekestraat 78, 8211 Zedelgem, BelgiumKBO/BCE: BE 1003.055.818
Summary

DR. TINEKE DE SUTTER has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €188,838 and a net result of €87,613. Its solvency ranks better than 29% of 20,598 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
DR. TINEKE DE SUTTERActiveChecked score 93/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€542,031total assets 2025
Equity
€188,838
Profit
€87,613
Turnover not published (micro format)
Financial health
93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
2025 accounts 1 day early
Why 93raises riskFounded in 2023lowers riskSector: Human health activities (NACE 86)Size: total assets €542,031Figures for financial year 2025 (filed 03-02-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 47% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 60+16
equity 34.8% of total assets
Liquidity 54=
short-term debt 25.3% · cash 10.6%
Profitability 89-3
return on assets 16.2%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,112 companies, NACE 86, micro)
Last 24 months 01-2025: 0.3%highest value 02-2025: < 0.1%▼ -0.3 percentage points vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.2%▲ +0.1 percentage points vs 01-2026 03-2026: < 0.1%▼ -0.2 percentage points vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: 0.1%▲ +0.1 percentage points vs 09-2026
Credit of up to €17,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity tight (current ratio 1.19, compared with 1.4 in 2024, below the usual 1.5; short-term debt: 25.3% and cash: 10.6% of total assets), and 65.2% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 29% on solvency, 28% on liquidity, 43% on profitability and 88% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €542,031
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Founded in 2023
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Figures for financial year 2025 (filed 03-02-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 day ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
1 day early
2024
18 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 10 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end24-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Equity above €150,000equity €188,838 ▲86.6%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Equity rose in 2025from €101,225 to €188,838 ▲ 86.6% View
  • One director decidessole director in office 1 View
  • Total assets 20252 financial years filed €542,031 View

By topic

Financials

Financial year
2025
Total assets
€542,031
Profit
€87,613
Solvency
34.8%
Total assets▲ 1.1%
Net result
20242025
Go to Financials

Timeline

Events
4
Since
2023
Next accounts
by 31-01-2027
  1. 08-12-2023Incorporation
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
06-12-2023
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Key facts about DR. TINEKE DE SUTTER

What is the company number of DR. TINEKE DE SUTTER?
1003.055.818. In Belgium the VAT number is the company number with BE in front: BE 1003.055.818.
Where is DR. TINEKE DE SUTTER based?
The registered office is at Moubekestraat 78, 8211 Zedelgem.Company details
What does DR. TINEKE DE SUTTER do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. TINEKE DE SUTTER?
Private limited company (BV).
When was DR. TINEKE DE SUTTER founded?
On 06-12-2023.
Is DR. TINEKE DE SUTTER still active?
Yes, DR. TINEKE DE SUTTER is an active enterprise in the KBO register.
How many employees does DR. TINEKE DE SUTTER have?
On average 0.5 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
What is the turnover of DR. TINEKE DE SUTTER?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is DR. TINEKE DE SUTTER profitable?
In financial year 2025, DR. TINEKE DE SUTTER made a profit of €87,613.
Where can I find the annual accounts of DR. TINEKE DE SUTTER?
DR. TINEKE DE SUTTER filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. TINEKE DE SUTTER due?
By 31-01-2027, for financial year 2026.Timeline

Companies related to DR. TINEKE DE SUTTER

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure